Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IOBT
IOBT logo

IOBT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IOBT News

IO Biotech Engages Raymond James as Financial Advisor Amid Workforce Reduction

Jan 30 2026Newsfilter

Piper Sandler Downgrades IO Biotech to Neutral Amid Strategic Review

Jan 27 2026Yahoo Finance

Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading

Jan 23 2026NASDAQ.COM

IO Biotech Evaluates Strategic Alternatives Amid $30.7M Cash Position

Jan 22 2026NASDAQ.COM

High Roller Technologies Inc Closes Direct Offering, Raises $25 Million

Jan 22 2026Benzinga

IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%

Jan 22 2026NASDAQ.COM

IO Biotech (IOBT) Explores Strategic Alternatives to Maximize Shareholder Value

Jan 21 2026seekingalpha

IO Biotech (IOBT) Explores Strategic Alternatives to Maximize Shareholder Value

Jan 21 2026Globenewswire

IOBT Events

01/30 08:40
IO Biotech Retains Raymond James as Financial Advisor
IO Biotech announced that it has retained Raymond James & Associates to serve as exclusive financial advisor to assist the company in its previously announced exploration of strategic alternatives. The company also announced that it is implementing cost-containment and cash conservation measures, including a significant reduction of the company's workforce, to reduce operating expenses while the company explores strategic alternatives.
01/26 16:30
Major Averages Close Broadly Higher as Investors Brace for Earnings Reports
The major averages closed broadly higher as traders brace for another week of corporate earnings reports, including from big names Microsoft, Apple, and Tesla, as well as the latest Federal Reserve interest rate decision slated for later this week.Investors are also monitoring even more tariff news, as President Trump over the weekend threatened 100% tariffs on all Canadian goods and products if the country reaches a trade agreement with China. However, Prime Minister Mark Carney said that Canada has "no intention" of pursuing such a trade deal. Additionally, rising tensions in Minnesota remain in focus following another fatal shooting of a U.S. citizen by an ICE officer over the weekend. Amid all the news coming out of the state, a group of more than 60 CEOs of Minnesota-based companies called for an "immediate de-escalation of tensions."Looking to commodities, gold continues to soar to record highs, surpassing the $5,000 mark for the first time.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:A group of more than 60 CEOs of Minnesota-based companies, including 3M, Target, UnitedHealth, and Best Buy, called for anin the stateNvidiaisin CoreWeaveUSA Rare Earthentered into a non-binding Letter of Intent with the U.S. government forMerckis no longer in talks to acquire Revolution Medicines,IonQSkyWater Technologyfor $35 per share in cash and stock2. WALL STREET CALLS:Meta Platformsto Buy at Rothschild & Co RedburnCiscoto Outperform at Evercore ISIBTIGof Fannie Maeand Freddie Macwith Buy ratings and $20 price targetsVaronisto Equal Weight from Overweight at Morgan StanleyPiperIO Biotech, sees no assurance strategic alternatives process will pan out favorably3. AROUND THE WEB:Oil majors that operate the Karachaganak field in Kazakhstan, including Eniand Shelllost an international arbitration case, leaving them liable to pay as much as $4B, Bloomberg reportsNikeis looking into a potential data breach, Reuters saysA foreign investment fund is in advanced talks to acquire Israeli medical aesthetics firm InModefor about $1.1B, or a 25% premium to its $882M valuation, which would result in the company being delisted, Calcalist reportsGooglehas acquired Common Sense Machines, which offers AI models that create 3D assets from 2D images, The Information saysMeta'sdecision to deprioritize VR in favor of AI and internet-connected glasses has chilled the VR industry, leading to concerns about its future, CNBC reports4. MOVERS:Land's Endhigher after announcing an agreement with WHP Global toTronoxincreases after providing Q4 guidance and announcing theSareptagains after reporting topline three-yearSatellogicfalls after pricing 7.4M shares at $4.73 inBlackRock TCP Capitallower after5. EARNINGS/GUIDANCESteel Dynamics, with EPS beating consensusBank of Hawaii, with CEO Peter Ho commenting, "Bank of Hawai'i completed 2025 with strong financial performance"Velocity Financialprovidedand FY25Trade Deskreaffirmed itsLakeland Financial, with CEO David Findlay commenting, "The Lake City Bank team produced a very strong fourth quarter with exceptional performance metrics"INDEXES:The Dow rose 313.69, or 0.64%, to 49,412.40, the Nasdaq gained 100.11, or 0.43%, to 23,601.36, and the S&P 500 advanced 34.62, or 0.50%, to 6,950.23.
01/26 12:11
Major Averages Rebound, Nasdaq Up 0.67%
The major averages were broadly higher near noon following last week's losses. Traders are bracing for another week of corporate earnings reports, including from big names Microsoft, Apple, and Tesla, as well as the latest Federal Reserve interest rate decision slated for later this week.Meanwhile, investors are also monitoring even more tariff news, as President Trump over the weekend threatened 100% tariffs on all Canadian goods and products if the country reaches a trade agreement with China, though Prime Minister Mark Carney said that Canada has "no intention" of pursuing such a trade deal. Additionally, rising tensions in Minnesota remain in focus following another fatal shooting of a U.S. citizen by an ICE officer over the weekend. Amid all the news coming out of the state, a group of more than 60 CEOs of Minnesota-based companies called for an "immediate deescalation of tensions."Looking to commodities, gold continues to soar to record highs, surpassing the $5,000 mark for the first time. Oil prices were lower near noon, meanwhile, as traders await more news coming out of Venezuela.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:A group of more than 60 CEOs of Minnesota-based companies, including 3M, Target, UnitedHealth, and Best Buy, called for anin the stateNvidiaisin CoreWeaveUSA Rare Earthentered into a non-binding Letter of Intent with the U.S. government forMerckis no longer in talks to acquire Revolution Medicines,IonQSkyWater Technologyfor $35 per share in cash and stock2. WALL STREET CALLS:Meta Platformsto Buy at Rothschild & Co RedburnCiscoto Outperform at Evercore ISIBTIGof Fannie Maeand Freddie Macwith Buy ratings and $20 price targetsVaronisto Equal Weight from Overweight at Morgan StanleyPiperIO Biotech, sees no assurance strategic alternatives process will pan out favorably3. AROUND THE WEB:A foreign investment fund is in advanced talks to acquire Israeli medical aesthetics firm InModefor about $1.1B, or a 25% premium to its $882M valuation, which would result in the company being delisted, Calcalist reportsGooglehas acquired Common Sense Machines, which offers AI models that create 3D assets from 2D images, The Information saysMeta'sdecision to deprioritize VR in favor of AI and internet-connected glasses has chilled the VR industry, leading to concerns about its future, CNBC reportsSome LVMHshareholders are looking for clarity on how and to whom CEO Bernard Arnault plans to hand over leadership of the company, Reuters saysSnowcap Research is short Patria Investmentsas its investigation suggests the company may be overstating performance and concealing losses within its flagship private equity and infrastructure funds4. MOVERS:Land's Endhigher after announcing anto form a new joint ventureTronoxincreases afterand announcing the closure of its pigment plant in ChinaSareptagains after reporting topline three-yearSatellogicfalls after pricing 7.4M shares at $4.73 inBlackRock TCP Capitallower after5. EARNINGS/GUIDANCESteel Dynamics, with EPS beating consensusBank of Hawaii, with CEO Peter Ho commenting, "Bank of Hawai'i completed 2025 with strong financial performance"Velocity Financialfor Q4 and FY25Trade Deskfor Q4Lakeland Financial, with CEO David Findlay commenting, "The Lake City Bank team produced a very strong fourth quarter with exceptional performance metrics"INDEXES:Near midday, the Dow was up 0.32%, or 155.73, to 49,254.44, the Nasdaq was up 0.67%, or 157.46, to 23,658.71, and the S&P 500 was up 0.56%, or 38.67, to 6,954.28.

IOBT Monitor News

IO Biotech Explores Strategic Alternatives Amid Financial Constraints

Jan 23 2026

IO Biotech explores strategic alternatives to maximize shareholder value

Jan 22 2026

IO Biotech explores strategic alternatives amid market uncertainty

Jan 21 2026

IOBT Earnings Analysis

No Data

No Data

People Also Watch